Perform phenotypic profiling in primary human cells to identify and
characterize candidate genes with therapeutic potential,
Published December 18, 2017 issue in Nature Genetics, a team led by researchers at the U.S. Department of Energy (DOE) Joint Genome Institute (JGI), a DOE Office of Science User Facility, and the Howard Hughes Medical Institute at the University of North Carolina at Chapel Hill (UNC) have exploited a catalog of bacterial genomes to identify and
characterize candidate genes that aid bacteria in adapting to plant environments, specifically genes involved in bacterial root colonization.
Published Dec. 18, 2017 in Nature Genetics, a team led by researchers at Joint Genome Institute (JGI) and the Howard Hughes Medical Institute at the University of North Carolina at Chapel Hill (UNC) have exploited a catalog of bacterial genomes to identify and
characterize candidate genes that aid bacteria in adapting to plant environments, specifically genes involved in bacterial root colonization.
Not exact matches
We have some
gene candidates for the next step of the pathway, and we are just starting to
characterize those.»
Previous genetic studies have examined the association of aspirin, NSAIDs, or both with colorectal cancer according to a limited number of
candidate genes or pathways.6 - 10 Thus, to comprehensively identify common genetic markers that
characterize individuals who may obtain differential benefit from aspirin and NSAIDs, we conducted a discovery - based, genome - wide analysis of
gene × environment interactions between regular use of aspirin, NSAIDs, or both and single - nucleotide polymorphisms (SNPs) in relation to risk of colorectal cancer.
In conclusion, our study
characterizes the biological function of DDX3 as a putative
candidate tumor suppressor
gene, at least in HCC and cutaneous SCC.